Skip to main content
Figure 1 | Journal of Hematology & Oncology

Figure 1

From: Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report

Figure 1

Positron Emission Tomography imaging scan prior to and following therapy. The top panels represent a coronal view whereas the bottom panels represent a horizontal section through the liver. (A) Pre-treatment imaging shows diffuse uptake in the liver, and lungs. (B) Subsequent imaging after 20 weeks of therapy with sorafenib reveals loss of uptake in these regions consistent with a dramatic reduction on tumor burden.

Back to article page